These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 5002304)

  • 1. Chemical and biological properties of rifampicin.
    Furesz S
    Antibiot Chemother; 1970; 16():316-51. PubMed ID: 5002304
    [No Abstract]   [Full Text] [Related]  

  • 2. Rifampicin, a general review.
    Binda G; Domenichini E; Gottardi A; Orlandi B; Ortelli E; Pacini B; Fowst G
    Arzneimittelforschung; 1971 Dec; 21(12):1907-77. PubMed ID: 4945790
    [No Abstract]   [Full Text] [Related]  

  • 3. Rifampicin.
    Polascik M; Golden B
    Ann Ophthalmol; 1971 Aug; 3(8):877-82. PubMed ID: 5005929
    [No Abstract]   [Full Text] [Related]  

  • 4. Rifampin: a semisynthetic derivative of rifamycin--a prototype for the future.
    Lester W
    Annu Rev Microbiol; 1972; 26():85-102. PubMed ID: 4562819
    [No Abstract]   [Full Text] [Related]  

  • 5. [Correlations between the biological properties and structure of rifampicin].
    Sensi P
    G Ital Mal Torace; 1969; ():Suppl 2:40-9. PubMed ID: 5357138
    [No Abstract]   [Full Text] [Related]  

  • 6. Rifampicin: a review.
    Drugs; 1971; 1(5):354-98. PubMed ID: 4949280
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmaceutical view of rifampicin (author's transl)].
    Tsutsumi S; Sakamoto Y; Gido S
    Repura; 1974; 43(1):1-7. PubMed ID: 4610307
    [No Abstract]   [Full Text] [Related]  

  • 8. Antimycobacterial activity of rifampicin.
    Lucchesi M; Mancini P
    Antibiot Chemother; 1970; 16():431-43. PubMed ID: 5002307
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental and clinical studies on the antituberculous activity of rifampicin alone or combined with other drugs.
    Nitti V
    Antibiot Chemother; 1970; 16():444-70. PubMed ID: 5002308
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibacterial activity of DL 473, a new semisynthetic rifamycin derivative.
    Arioli V; Berti M; Carniti G; Randisi E; Rossi E; Scotti R
    J Antibiot (Tokyo); 1981 Aug; 34(8):1026-32. PubMed ID: 7319918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicologic and pharmacologic aspects of rifampin.
    Radner DB
    Chest; 1973 Aug; 64(2):213-6. PubMed ID: 4199024
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rimactan. Experimental studies and clinical experience].
    Meyer-Rohn J; Lautenschlager HJ
    Munch Med Wochenschr; 1969 Aug; 111(33):1646-50. PubMed ID: 5395306
    [No Abstract]   [Full Text] [Related]  

  • 13. Suitability of rifampicin for intermittent administration in the treatment of tuberculosis.
    Dickinson JM; Mitchison DA
    Tubercle; 1970 Mar; 51(1):82-94. PubMed ID: 4992976
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tuberculostatic activity of various rifampicin derivatives in vitro and in vivo].
    Kochanova NK; Miakotina EN; Bellendir EN; Boiarkina SK; Iudelevich VI
    Probl Tuberk; 1983 Jun; (6):65-8. PubMed ID: 6410375
    [No Abstract]   [Full Text] [Related]  

  • 15. Rifampicin for non-tuberculous infections?
    Grüneberg RN; Emmerson AM; Cremer AW
    Chemotherapy; 1985; 31(4):324-8. PubMed ID: 3928283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antibacterial activity of a new 3-azinomethyl-rifamycin.
    Strippoli V; Bruzzese T; Galli R; Simonetti N; Tronci N
    Farmaco Sci; 1988; 43(7-8):619-25. PubMed ID: 3147199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental antitubercular activity of rifampicin, a derivative of rifamycin SV].
    Grumbach F; Rist N
    Rev Tuberc Pneumol (Paris); 1967; 31(6):749-62. PubMed ID: 4988378
    [No Abstract]   [Full Text] [Related]  

  • 18. [Rifampicin and its clinical use].
    Fafrowicz B
    Wiad Lek; 1971 Jul; 24(3):233-8. PubMed ID: 4926926
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of the pathogenicity, in the guinea-pig, of strains of mycobacterium tuberculosis resistant to rifampicin].
    Timoşca S; Petreanu V; Labă E; Georgescu M; Martinescu T
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):309-14. PubMed ID: 6304844
    [No Abstract]   [Full Text] [Related]  

  • 20. [Rifampicin resistence and virulence of M. tuberculosis for guinea pigs].
    Schröder KH; Koperska C
    Zentralbl Bakteriol Orig A; 1972 Jan; 219(1):112-3. PubMed ID: 4402403
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.